UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K


CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934


Date of report (Date of earliest event reported): October 20, 2010

PACIFICHEALTH LABORATORIES, INC.
(Exact Name of Registrant as Specified in Its Charter)

Delaware
(State or Other Jurisdiction of Incorporation)

000-23495
 
22-3367588
(Commission File Number)
 
(IRS Employer Identification No.)
     
100 Matawan Road,  Suite 420, Matawan, NJ
 
07747-3913
(Address of Principal Executive Offices)
 
(Zip Code)
 
 
 (732) 739-2900
 (Registrant’s Telephone Number, Including Area Code)
 
 
 
 (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

 
o
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
 
o
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
 
o
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
 
o
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
Item 8.01.    Other Events

The registrant issued a press release on October 20, 2010 announcing significant changes in the registrant’s business strategy and emphasis. The press release is attached to this Report as Exhibit 99.1.

Item 9.01.    Financial Statements and Exhibits.
     
 
(d)
Exhibits.
     
Exhibit
Number
 
Description 
99.1
 
Press Release dated October 20, 2010.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

   
PACIFICHEALTH LABORATORIES, INC.
         
         
Dated: October 21, 2010
 
By:
/s/ Stephen P. Kuchen
 
     
Stephen P. Kuchen
 
     
Chief Financial Officer
 
 
 
 
 
 
Exhibit Index

Exhibit
Number
 
Description 
99.1
 
Press Release dated October 20, 2010.
 
 
 
 
 
PacificHealth Laboratories (CE) (USOTC:PHLI)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025 Plus de graphiques de la Bourse PacificHealth Laboratories (CE)
PacificHealth Laboratories (CE) (USOTC:PHLI)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025 Plus de graphiques de la Bourse PacificHealth Laboratories (CE)